Prophylactic effect of papaverine prolonged-release pellets on cerebral vasospasm in dogs

Neurosurgery

Volumn 42, Issue 1, 1998, Pages 109-116

  Shiokawa, Kazuhiko ^a   Kasuya, Hidetoshi ^a   Miyajima, Makoto ^b   Izawa, Masahiro ^a   Takakura, Kintomo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Cerebral vasospasm; Drug delivery system; Papaverine; Polyglycolic acid; Polylactic acid; Subarachnoid hemorrhage

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; PAPAVERINE; PL 1500L; PL 2500L; PLACEBO; PLG 1600HL; PLG 1600ML; POLYGLACTIN; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CEREBRAL ARTERY; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CRANIECTOMY; DOG; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG PELLET; FEMALE; INTERNAL CAROTID ARTERY; INTRACISTERNAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SUBARACHNOID HEMORRHAGE;

ANIMALS; BLOOD; CEREBROSPINAL FLUID; DELAYED-ACTION PREPARATIONS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTRACRANIAL EMBOLISM AND THROMBOSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; PAPAVERINE; PREVENTIVE MEDICINE;

EID: 0031886797     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199801000-00022     Document Type: Article

References (23)

1. Athanasiou KA, Niederauer GG, Agrawal CM: Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers. Biomaterials 17:93-102, 1996.
2. Espinosa FJ: Streptokinase in the treatment of cerebral vasospasm after subarachnoid hemorrhage in dogs, in Findlay JM (ed): Cerebral Vasospasm. Amsterdam, Elsevier Science Publishers BV, 1993, pp 491-495.
3. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys: Part 1 - Clinical and radiological findings. J Neurosurg 60:1167-1175, 1984.
4. Gupta PK, Mehta RC, Douglas RH, DeLuca PP: In vivo evaluation of biodegradable progesterone microspheres in mares. Pharm Res 9:1502-1506, 1992.
5. Heffez DS, Leong KW: Sustained release of papaverine for the treatment of cerebral vasospasm: In vitro evaluation of release kinetics and biological activity. J Neurosurg 77:783-787, 1992.
6. Inoue T, Shimizu H, Kaminuma T, Tajima M, Watabe K, Yoshimoto T: Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery 39:984-990, 1996.
7. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K: Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77:842-847, 1992.
8. Kanamaru K, Weir BKA, Findlay JM, Krueger CA, Cook DA: Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg 71:909-915, 1989.
9. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77:848-852, 1992.
10. Kulkarni PK, Pani KC, Neuman C, Leonard F: Polylactic acid for surgical implants. Arch Surg 93:839-843, 1966.
11. Kuwayama A, Zervas NT, Shintani A, Pickren KS: Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm. Stroke 3:27-33, 1972.
12. Miyamoto S, Kikuchi H, Ikeda Y, Hyon SH, Tabata Y, Kusanoi Y, Wada R, Nagata I, Yamagata S, Kaneko T, Kubo H: Thrombolysis of subarachnoid clot using tissue plasminogen activator: The development of a drug delivery system using biodegradable polymer [in Japanese]. Surg Cereb Stroke 19:308-311, 1991.
13. Nagai H, Noda S, Mabe H: Experimental cerebral vasospasm: Part 2 - Effects of vasoactive drugs and sympathectomy on early and late spasm. J Neurosurg 42:420-428, 1975.
14. Oda Y, Konishi T, Okumura T, Kang Y, Kikuchi H, Kamijo Y: Treatment of vasospasm after ruptured cerebral aneurysms by 'Pellet-cisternal-drain:PCD' containing sustained-release vasodilators [in Japanese]. No-shinkeigeka 16:965-970, 1988.
15. Oda Y, Okumura T, Morimoto M, Murata T, Uchida Y, Mori K: Topical application of papaverine for cerebral vasospasm using prolonged-release pellet: Basic experiment [in Japanese]. No-shinkeigeka 11:1027-1034, 1983.
16. Ogata M, Marshall BM, Lougheed WM: Observations on the effects of intrathecal papaverine in experimental vasospasm. J Neurosurg 38:20-25, 1973.
17. Sampath SS, Garvin K, Robinson DH: Preparation and characterization of biodegradable poly(L-lactic acid) gentamicin delivery systems. Int J Pharm 78:165-174, 1992.
18. Segawa H, Saito I, Okada T, Nagayama I, Kitamura K, Takakura K, Sano S: Efficacy of intracisternal papaverine on symptomatic vasospasm [in Japanese]. No Shinkei Geka 14:847-854, 1986.
19. Singh M, Singh A, Talwar GP: Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules. Pharm Res 8:958-961, 1991.
20. Therin M, Christel P, Li S, Carreau H, Vert M: In vivo degradation of massive poly(α-hydroxy acids): Validation of in vitro findings. Biomaterials 13:594-600, 1992.
21. Toda N: The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog. J Pharmacol Exp Ther 191:139-146, 1974.
22. Vollmer DG, Jane JS, Torner JC, Kassell NF: Intracisternal papaverine reverses experimental cerebral vasospasm in a rabbit model, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, 1988, pp 425-431.
23. Wilkins RH: Attempts at prevention or treatment of intracranial arterial spasm: An update. Neurosurgery 18:808-825, 1986.